CDMO Avid Bioservices, Inc.: institutional ownership and insider trading
3 funds reported holding $13.4M of Avid Bioservices, Inc. in their latest 13F filings; in Q2 2025 funds net bought $0, with 0 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $150M and net income of −$152M.
CDMO revenue and earnings
- Quarter ended Oct 31, 2024: revenue $33.5M, net income −$17.4M, EPS -0.27
- Quarter ended Jul 31, 2024: revenue $40.2M, net income −$5.53M, EPS -0.09
- Quarter ended Apr 30, 2024: revenue $43.0M, net income −$123M, EPS -1.96
- Quarter ended Jan 31, 2024: revenue $33.8M, net income −$6.01M, EPS -0.09
Largest institutional holders of CDMO
- Nuveen Asset Management, LLC — $9.79M
- CIGOGNE MANAGEMENT SA — $2.34M
- Zions Bancorporation, N.A. — $1.32M
Recent CDMO insider trades
- Jan 10, 2025: Richieri Richard A. sold 2,483 shares ($30.7K)
- Dec 26, 2024: Richieri Richard A. sold 3,843 shares ($47.0K)
- Dec 26, 2024: Kwietniak Matthew R. sold 13,390 shares ($164K)
- Dec 26, 2024: Hart Daniel R sold 22,813 shares ($279K)
5%+ owners
- AltraVue Capital, LLC: 5.9% (Schedule 13G/A, filed Jan 14, 2025)